Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2023-03-08 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司关于自愿披露公司及全资子公司获得发明专利的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of two invention patents from the National Intellectual Property Office. It details the patent numbers, application dates, and the impact of these patents on the company's technology and products. There is no financial data, no mention of financial results, no regulatory certifications, or meeting-related information. The document is an official announcement about intellectual property rights, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is also not related to management changes, voting results, or legal proceedings. Given the nature of the content and the absence of other specific categories, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2023-03-08 Chinese
科美诊断技术股份有限公司关于持股5%以上股东减持计划数量过半暨权益变动达到1%的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a shareholding reduction plan by shareholders holding more than 5% of the company's shares. It details the number of shares reduced, the shareholders involved, and the impact on shareholding percentages. The document includes specific dates, share quantities, and regulatory references related to shareholding changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about changes in major shareholdings and share reduction progress. This fits the definition of a Major Shareholding Notification (MRQ). The document length is sufficient and contains detailed information about shareholding changes, not just a brief notice or a report publication announcement.
2023-02-28 Chinese
科美诊断技术股份有限公司2022年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2022年度业绩快报公告" which translates to "2022 Annual Performance Express Report Announcement." It contains preliminary financial data for the year 2022, including revenue, profit, and other key financial metrics. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be in the company's 2022 Annual Report. The document is relatively short (1754 characters) and serves as a brief announcement of preliminary financial results rather than a full comprehensive report. It does not contain detailed financial statements or extensive analysis typical of an Annual Report (10-K) or Interim Report (IR). It is also not a certification or regulatory filing. Therefore, this document fits best as an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only. FY 2022
2023-02-27 Chinese
科美诊断技术股份有限公司关于股东持股比例降至5%以下的权益变动提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a detailed announcement about a shareholder's reduction in shareholding below the 5% threshold. It includes specifics about the shareholder, the number of shares reduced, dates of transactions, and confirms that the change does not affect control of the company. The document references a "简式权益变动报告书" (Simplified Equity Change Report) and provides detailed shareholding changes. This matches the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels crossing thresholds. The document is not a full financial report, earnings release, or management report, nor is it a proxy or AGM material. It is not a regulatory filing or report publication announcement because it contains substantive details about the shareholding change itself. Therefore, the correct classification is MRQ with high confidence.
2023-02-23 Chinese
科美诊断技术股份有限公司简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding percentages of certain shareholders in 科美诊断技术股份有限公司, including specifics on share reduction, shareholding percentages before and after the change, and the methods of share disposal (concentrated bidding and block trades). The document references compliance with Chinese securities laws and disclosure regulations related to equity changes. It is a detailed report on changes in major shareholdings, specifically noting that the shareholding dropped below 5%. There is no indication that this is an annual report, earnings release, or any other type of financial report. The content matches the definition of "Major Shareholding Notification" (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length (7876 characters) and detailed content confirm it is the report itself, not just an announcement of a report. Therefore, the correct classification is MRQ with high confidence.
2023-02-23 Chinese
科美诊断技术股份有限公司简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding by specific shareholders, including the reduction of shares held by the information disclosure obligors. The document includes detailed information about the shareholders, their shareholding percentages before and after the change, the methods of share reduction (block trades and centralized bidding), and the timeline of these transactions. It also references compliance with relevant securities laws and disclosure obligations. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a formal notification of a significant change in share ownership exceeding 5%, which fits the definition of a Major Shareholding Notification (MRQ). The document is substantive and not merely an announcement or certification, so it is not classified as RNS or RPA. Therefore, the appropriate classification is MRQ with high confidence.
2023-02-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.